Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

X4 Pharmaceuticals, Inc. Common Stock

XFOR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of XFOR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
XFOR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
XFOR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
XFOR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in XFOR holdings by institutional investors

Quarterly net insider trading by XFOR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for XFOR

Quiver Logo

No former government officials on record as having lobbied for XFOR

Revolving Door Dashboard

XFOR Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

XFOR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
XFOR Income Statement
XFOR Balance Sheet
XFOR Cash Flow
U.S. Patents

New XFOR patent grants

  • Patent Title: Methods for treating neutropenia Sep. 08, 2026
  • Patent Title: Methods for treating neutropenia Aug. 05, 2025
  • Patent Title: Methods for treating neutropenia Apr. 29, 2025
  • Patent Title: Compositions of cxcr4 inhibitors and methods of preparation and use Oct. 15, 2024
  • Patent Title: Cxcr4 inhibitors and uses thereof Oct. 10, 2023
  • Patent Title: Compositions of cxcr4 inhibitors and methods of preparation and use Jun. 13, 2023
  • Patent Title: Antibodies targeting a galactan-based o-antigen of k. pneumoniae Oct. 11, 2022
  • Patent Title: Methods for treating cancer Jun. 14, 2022
  • Patent Title: Methods for treating cancer May. 24, 2022
  • Patent Title: Cxcr4 inhibitors and uses thereof May. 17, 2022
  • Patent Title: Cxcr4 inhibitors and uses thereof Apr. 19, 2022
  • Patent Title: Methods for treating immunodeficiency disease Jan. 11, 2022
  • Patent Title: Compositions of cxcr4 inhibitors and methods of preparation and use Jun. 29, 2021
  • Patent Title: Cxcr4 inhibitors and uses thereof Apr. 27, 2021
  • Patent Title: Methods for treating cancer Mar. 23, 2021
  • Patent Title: Mdr Mar. 09, 2021
  • Patent Title: Cxcr4 inhibitors and uses thereof Sep. 01, 2020
  • Patent Title: Compositions of cxcr4 inhibitors and methods of preparation and use Feb. 04, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to XFOR from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
XFOR News

Recent insights relating to XFOR

CNBC Recommendations

Recent picks made for XFOR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XFOR

XFOR Analyst Ratings

XFOR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
XFOR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $XFOR stock a Buy, Sell, or Hold?

  • What is the price target for $XFOR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

XFOR Top Shareholders
Shareholder
Shares Held
XFOR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $XFOR stock?

  • Who owns the most shares of $XFOR stock?

  • What funds own $XFOR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

XFOR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view XFOR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About XFOR

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

  • Address Boston, MA
  • Market Cap 308.3 million
  • Employees 45
  • Industrial Classification Biological Products, (No Diagnostic Substances)

X4 Pharmaceuticals, Inc. Common Stock (XFOR) Historical Stock Prices

X4 Pharmaceuticals, Inc. Common Stock (XFOR) closed at $3.11 on September 23, 2026. Over the past year its adjusted close ranged from $2.86 to $4.67. Daily prices go back to November 16, 2017, 2,222 trading days in all.

  • 1 month-23.21%
  • 3 months-23.96%
  • Year to date-22.25%
  • 1 year-9.86%
  • 3 years-90.03%
  • 5 years-98.13%
  • Max-77.83%
See every congressional and insider trade on the XFOR price chart

Quiver Premium charts XFOR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 3.41 3.42 3.04 3.11 3.11 2,309,554
Sep 22, 2026 3.52 3.57 3.40 3.43 3.43 923,763
Sep 21, 2026 3.58 3.58 3.46 3.50 3.50 444,355
Sep 18, 2026 3.48 3.63 3.48 3.58 3.58 1,543,428
Sep 17, 2026 3.56 3.58 3.41 3.50 3.50 635,053
Sep 16, 2026 3.63 3.65 3.35 3.51 3.51 973,335
Sep 15, 2026 3.60 3.64 3.31 3.62 3.62 2,081,151
Sep 14, 2026 3.51 3.71 3.47 3.62 3.62 1,018,021
Sep 11, 2026 3.44 3.55 3.24 3.50 3.50 1,252,949
Sep 10, 2026 3.60 3.67 3.31 3.40 3.40 2,570,217
Sep 9, 2026 3.50 3.67 3.45 3.60 3.60 1,402,279
Sep 8, 2026 4.00 4.13 3.19 3.50 3.50 2,323,934
Sep 4, 2026 4.01 4.08 4.00 4.04 4.04 168,162
Sep 3, 2026 4.06 4.07 3.99 4.04 4.04 409,440
Sep 2, 2026 4.10 4.17 4.01 4.04 4.04 360,955
Sep 1, 2026 3.97 4.11 3.97 4.07 4.07 203,867
Aug 31, 2026 4.02 4.10 4.00 4.04 4.04 245,892
Aug 28, 2026 4.22 4.23 4.00 4.04 4.04 356,380
Aug 27, 2026 4.18 4.39 4.14 4.23 4.23 597,238
Aug 26, 2026 4.16 4.23 4.08 4.17 4.17 707,142
Aug 25, 2026 4.05 4.18 4.00 4.16 4.16 390,755
Aug 24, 2026 4.03 4.09 3.94 4.05 4.05 299,166
Aug 21, 2026 4.05 4.17 4.00 4.04 4.04 1,219,601
Aug 20, 2026 4.12 4.22 3.99 4.03 4.03 561,210
Aug 19, 2026 4.25 4.35 4.14 4.16 4.16 406,049
Aug 18, 2026 4.27 4.32 4.14 4.21 4.21 362,085
Aug 17, 2026 4.20 4.33 4.13 4.30 4.30 1,095,472
Aug 14, 2026 4.26 4.33 4.05 4.22 4.22 840,932
Aug 13, 2026 4.28 4.46 4.19 4.29 4.29 1,127,769
Aug 12, 2026 4.29 4.55 4.25 4.29 4.29 1,041,027
Aug 11, 2026 4.19 4.42 4.13 4.28 4.28 1,079,917
Aug 10, 2026 4.60 4.63 4.21 4.25 4.25 658,228
Aug 7, 2026 4.26 4.82 4.21 4.64 4.64 1,597,331
Aug 6, 2026 4.15 4.26 4.07 4.17 4.17 447,777
Aug 5, 2026 4.26 4.28 4.08 4.15 4.15 372,617
Aug 4, 2026 4.10 4.33 4.10 4.29 4.29 604,731
Aug 3, 2026 4.01 4.10 3.96 4.09 4.09 364,079
Jul 31, 2026 4.00 4.05 3.87 3.98 3.98 415,501
Jul 30, 2026 3.96 4.23 3.96 4.00 4.00 504,599
Jul 29, 2026 3.93 4.07 3.88 4.00 4.00 875,614
Jul 28, 2026 3.95 3.96 3.71 3.93 3.93 861,700
Jul 27, 2026 3.86 4.00 3.83 3.94 3.94 360,034
Jul 24, 2026 4.00 4.00 3.77 3.85 3.85 573,622
Jul 23, 2026 3.66 4.01 3.58 3.99 3.99 579,989
Jul 22, 2026 3.67 3.77 3.56 3.69 3.69 678,169
Jul 21, 2026 3.68 3.76 3.62 3.69 3.69 430,203
Jul 20, 2026 3.84 3.89 3.60 3.68 3.68 729,887
Jul 17, 2026 3.73 3.85 3.70 3.82 3.82 461,940
Jul 16, 2026 3.88 3.88 3.74 3.83 3.83 504,453
Jul 15, 2026 4.03 4.04 3.78 3.90 3.90 539,464
Jul 14, 2026 4.02 4.18 3.96 4.02 4.02 1,140,808
Jul 13, 2026 4.42 4.48 4.01 4.05 4.05 642,327
Jul 10, 2026 4.21 4.44 3.91 4.41 4.41 918,438
Jul 9, 2026 3.95 4.02 3.87 3.96 3.96 447,293
Jul 8, 2026 3.87 3.98 3.84 3.96 3.96 464,632
Jul 7, 2026 4.03 4.08 3.86 3.94 3.94 528,246
Jul 6, 2026 4.14 4.17 3.99 4.03 4.03 542,461
Jul 2, 2026 4.15 4.30 4.08 4.13 4.13 678,995
Jul 1, 2026 4.64 4.70 4.06 4.08 4.08 807,032
Jun 30, 2026 4.23 4.70 4.20 4.67 4.67 1,104,537
Jun 29, 2026 4.06 4.25 4.00 4.23 4.23 591,595
Jun 26, 2026 3.98 4.24 3.98 4.02 4.02 10,479,698
Jun 25, 2026 4.13 4.22 3.92 3.99 3.99 633,099
Jun 24, 2026 4.05 4.17 4.00 4.09 4.09 686,392
Jun 23, 2026 4.06 4.22 3.99 4.00 4.00 352,749
Jun 22, 2026 4.22 4.42 4.11 4.12 4.12 438,105
Jun 18, 2026 4.03 4.28 4.01 4.22 4.22 866,269
Jun 17, 2026 4.06 4.11 3.98 4.05 4.05 403,777
Jun 16, 2026 4.10 4.14 3.99 4.04 4.04 461,102
Jun 15, 2026 4.03 4.12 4.00 4.08 4.08 511,668
Jun 12, 2026 3.93 4.02 3.90 4.00 4.00 501,560
Jun 11, 2026 3.71 3.89 3.67 3.88 3.88 471,521
Jun 10, 2026 3.84 4.00 3.72 3.73 3.73 399,642
Jun 9, 2026 3.71 3.95 3.71 3.85 3.85 434,522
Jun 8, 2026 3.91 3.94 3.66 3.71 3.71 451,732
Jun 5, 2026 4.00 4.02 3.76 3.83 3.83 447,734
Jun 4, 2026 3.95 4.17 3.95 4.01 4.01 276,981
Jun 3, 2026 4.04 4.09 3.96 3.97 3.97 400,253
Jun 2, 2026 4.25 4.25 4.01 4.04 4.04 475,296
Jun 1, 2026 4.24 4.33 4.09 4.11 4.11 469,275
May 29, 2026 4.12 4.36 4.05 4.31 4.31 878,517
May 28, 2026 4.01 4.18 3.99 4.14 4.14 296,422
May 27, 2026 3.98 4.16 3.98 4.03 4.03 213,501
May 26, 2026 4.07 4.15 3.97 4.00 4.00 287,726
May 22, 2026 4.05 4.20 4.00 4.04 4.04 177,820
May 21, 2026 3.71 4.07 3.71 4.04 4.04 254,735
May 20, 2026 3.65 3.85 3.58 3.77 3.77 271,760
May 19, 2026 3.67 3.68 3.56 3.64 3.64 446,986
May 18, 2026 3.99 3.99 3.58 3.68 3.68 494,357
May 15, 2026 3.97 4.06 3.86 3.94 3.94 263,889
May 14, 2026 4.20 4.21 3.97 4.00 4.00 264,582
May 13, 2026 4.32 4.37 4.21 4.23 4.23 245,393
May 12, 2026 4.48 4.50 4.20 4.34 4.34 401,007
May 11, 2026 4.37 4.60 4.37 4.50 4.50 449,869
May 8, 2026 4.35 4.56 4.30 4.43 4.43 427,931
May 7, 2026 4.22 4.38 4.19 4.29 4.29 329,911
May 6, 2026 4.21 4.50 4.13 4.38 4.38 651,689
May 5, 2026 4.23 4.33 4.11 4.20 4.20 278,145
May 4, 2026 4.15 4.30 4.13 4.21 4.21 305,700
May 1, 2026 4.05 4.24 4.05 4.19 4.19 246,343
Apr 30, 2026 4.13 4.16 4.00 4.07 4.07 287,472
Apr 29, 2026 4.20 4.21 3.97 4.10 4.10 327,008
Apr 28, 2026 4.16 4.28 4.03 4.12 4.12 244,664
Apr 27, 2026 4.08 4.33 4.08 4.21 4.21 369,854
Apr 24, 2026 4.20 4.28 4.04 4.11 4.11 527,042
Apr 23, 2026 4.40 4.66 4.24 4.28 4.28 635,203
Apr 22, 2026 4.20 4.45 4.12 4.42 4.42 681,065
Apr 21, 2026 4.23 4.25 4.12 4.17 4.17 232,469
Apr 20, 2026 4.23 4.31 4.15 4.19 4.19 215,561
Apr 17, 2026 4.19 4.38 4.19 4.29 4.29 301,247
Apr 16, 2026 4.30 4.35 4.06 4.14 4.14 332,173
Apr 15, 2026 4.18 4.34 4.18 4.33 4.33 436,705
Apr 14, 2026 4.14 4.34 4.14 4.20 4.20 227,151
Apr 13, 2026 4.10 4.23 4.05 4.13 4.13 228,931
Apr 10, 2026 4.06 4.13 3.99 4.10 4.10 235,122
Apr 9, 2026 4.02 4.16 3.99 4.07 4.07 418,756
Apr 8, 2026 3.85 4.13 3.79 4.05 4.05 1,073,810
Apr 7, 2026 4.01 4.07 3.70 3.73 3.73 686,955
Apr 6, 2026 4.24 4.34 4.07 4.07 4.07 231,992
Apr 2, 2026 4.23 4.43 4.17 4.24 4.24 206,099
Apr 1, 2026 4.13 4.47 4.13 4.35 4.35 446,622
Mar 31, 2026 3.97 4.24 3.97 4.13 4.13 375,778
Mar 30, 2026 3.98 4.27 3.89 3.99 3.99 358,556
Mar 27, 2026 4.31 4.35 4.03 4.04 4.04 320,161
Mar 26, 2026 4.08 4.51 3.99 4.31 4.31 655,078
Mar 25, 2026 3.85 4.17 3.85 4.09 4.09 402,518
Mar 24, 2026 4.07 4.07 3.81 3.82 3.82 284,849
Mar 23, 2026 4.34 4.36 4.00 4.07 4.07 361,899
Mar 20, 2026 4.14 4.50 4.10 4.28 4.28 684,979
Mar 19, 2026 4.01 4.17 3.92 4.17 4.17 260,409
Mar 18, 2026 4.16 4.42 3.98 4.05 4.05 559,199
Mar 17, 2026 3.75 4.23 3.63 4.23 4.23 619,181
Mar 16, 2026 3.64 3.69 3.53 3.56 3.56 443,120
Mar 13, 2026 3.88 4.05 3.68 3.69 3.69 216,950
Mar 12, 2026 4.27 4.27 3.87 3.88 3.88 308,427
Mar 11, 2026 4.63 4.67 4.31 4.33 4.33 610,628
Mar 10, 2026 4.21 4.83 4.21 4.66 4.66 1,999,169
Mar 9, 2026 3.75 4.16 3.70 4.15 4.15 590,519
Mar 6, 2026 3.65 3.86 3.65 3.76 3.76 282,179
Mar 5, 2026 3.51 3.71 3.42 3.70 3.70 438,119
Mar 4, 2026 3.30 3.52 3.30 3.50 3.50 419,368
Mar 3, 2026 3.37 3.45 3.25 3.33 3.33 1,194,963
Mar 2, 2026 3.31 3.44 3.23 3.40 3.40 267,813
Feb 27, 2026 3.25 3.44 3.20 3.44 3.44 793,190
Feb 26, 2026 3.43 3.53 3.21 3.25 3.25 830,158
Feb 25, 2026 3.39 3.56 3.39 3.44 3.44 978,066
Feb 24, 2026 3.17 3.43 3.14 3.39 3.39 221,938
Feb 23, 2026 3.12 3.25 3.10 3.16 3.16 251,809
Feb 20, 2026 3.05 3.19 3.01 3.16 3.16 322,248
Feb 19, 2026 2.97 3.15 2.96 3.10 3.10 573,576
Feb 18, 2026 3.10 3.12 2.83 2.99 2.99 1,081,008
Feb 17, 2026 3.40 3.42 3.09 3.10 3.10 643,193
Feb 13, 2026 3.39 3.51 3.38 3.41 3.41 160,815
Feb 12, 2026 3.49 3.49 3.13 3.37 3.37 540,485
Feb 11, 2026 3.69 3.78 3.42 3.43 3.43 428,805
Feb 10, 2026 3.53 3.75 3.52 3.71 3.71 603,100
Feb 9, 2026 3.57 3.63 3.53 3.55 3.55 195,264
Feb 6, 2026 3.70 3.82 3.52 3.56 3.56 831,851
Feb 5, 2026 3.78 3.83 3.65 3.66 3.66 622,365
Feb 4, 2026 3.99 4.00 3.75 3.85 3.85 999,120
Feb 3, 2026 3.98 4.00 3.79 4.00 4.00 463,653
Feb 2, 2026 3.66 4.00 3.66 3.98 3.98 385,966
Jan 30, 2026 3.61 3.76 3.61 3.70 3.70 255,569
Jan 29, 2026 3.62 3.71 3.59 3.69 3.69 226,788
Jan 28, 2026 3.70 3.73 3.59 3.62 3.62 204,442
Jan 27, 2026 3.59 3.71 3.58 3.70 3.70 191,745
Jan 26, 2026 3.69 3.73 3.60 3.63 3.63 255,062
Jan 23, 2026 3.74 3.79 3.68 3.70 3.70 221,981
Jan 22, 2026 3.78 3.88 3.72 3.76 3.76 354,658
Jan 21, 2026 3.66 3.75 3.60 3.75 3.75 192,993
Jan 20, 2026 3.62 3.78 3.57 3.67 3.67 327,747
Jan 16, 2026 3.62 3.75 3.58 3.70 3.70 269,968
Jan 15, 2026 3.77 3.82 3.56 3.62 3.62 548,612
Jan 14, 2026 3.87 3.92 3.77 3.77 3.77 313,130
Jan 13, 2026 3.98 4.00 3.84 3.87 3.87 338,545
Jan 12, 2026 4.00 4.00 3.73 3.90 3.90 353,996
Jan 9, 2026 4.14 4.24 3.98 4.00 4.00 1,089,038
Jan 8, 2026 3.97 4.04 3.86 4.04 4.04 352,471
Jan 7, 2026 3.99 4.07 3.96 4.00 4.00 422,103
Jan 6, 2026 3.82 3.99 3.79 3.96 3.96 243,875
Jan 5, 2026 3.90 3.94 3.74 3.84 3.84 269,535
Jan 2, 2026 4.08 4.08 3.83 3.89 3.89 340,316
Dec 31, 2025 4.17 4.21 3.93 4.00 4.00 340,105
Dec 30, 2025 4.28 4.30 4.08 4.16 4.16 472,715
Dec 29, 2025 4.43 4.45 4.22 4.30 4.30 301,609
Dec 26, 2025 4.43 4.51 4.24 4.50 4.50 536,942
Dec 24, 2025 4.12 4.55 4.07 4.42 4.42 823,751
Dec 23, 2025 4.08 4.27 4.01 4.12 4.12 853,409
Dec 22, 2025 3.64 4.21 3.62 4.10 4.10 1,170,339
Dec 19, 2025 3.66 3.79 3.50 3.60 3.60 5,170,397
Dec 18, 2025 3.60 3.83 3.60 3.66 3.66 573,505
Dec 17, 2025 3.72 3.86 3.48 3.51 3.51 687,347
Dec 16, 2025 3.73 3.86 3.69 3.71 3.71 463,831
Dec 15, 2025 3.94 4.00 3.76 3.76 3.76 514,148
Dec 12, 2025 3.87 4.08 3.77 3.91 3.91 525,555
Dec 11, 2025 3.89 4.00 3.84 3.88 3.88 573,655
Dec 10, 2025 3.65 3.93 3.54 3.89 3.89 602,387
Dec 9, 2025 3.80 3.85 3.52 3.64 3.64 1,239,319
Dec 8, 2025 3.95 3.95 3.70 3.84 3.84 743,391
Dec 5, 2025 3.94 4.07 3.75 3.98 3.98 883,693
Dec 4, 2025 3.25 3.81 3.25 3.80 3.80 655,818
Dec 3, 2025 3.17 3.32 3.05 3.25 3.25 508,987
Dec 2, 2025 3.17 3.32 3.13 3.19 3.19 729,535
Dec 1, 2025 3.64 3.65 3.13 3.15 3.15 1,340,413
Nov 28, 2025 3.68 3.82 3.62 3.64 3.64 240,502
Nov 26, 2025 3.81 3.86 3.64 3.64 3.64 689,180
Nov 25, 2025 3.83 3.90 3.78 3.80 3.80 419,795
Nov 24, 2025 3.74 3.84 3.68 3.80 3.80 498,037
Nov 21, 2025 3.73 3.78 3.57 3.75 3.75 250,152
Nov 20, 2025 3.71 3.85 3.57 3.70 3.70 644,717
Nov 19, 2025 3.60 3.79 3.50 3.65 3.65 575,439
Nov 18, 2025 3.63 3.66 3.50 3.60 3.60 527,972
Nov 17, 2025 3.64 3.86 3.61 3.66 3.66 579,234
Nov 14, 2025 3.62 3.73 3.61 3.66 3.66 282,069
Nov 13, 2025 3.81 3.85 3.66 3.73 3.73 277,994
Nov 12, 2025 3.53 3.89 3.50 3.87 3.87 620,700
Nov 11, 2025 3.60 3.63 3.49 3.53 3.53 573,823
Nov 10, 2025 3.71 3.85 3.60 3.63 3.63 518,213
Nov 7, 2025 3.48 3.76 3.26 3.71 3.71 638,626
Nov 6, 2025 3.62 3.69 3.43 3.50 3.50 528,088
Nov 5, 2025 3.72 3.90 3.55 3.55 3.55 721,215
Nov 4, 2025 4.00 4.12 3.94 3.97 3.97 694,168
Nov 3, 2025 4.03 4.15 3.95 4.09 4.09 815,158
Oct 31, 2025 3.99 4.11 3.91 4.04 4.04 649,363
Oct 30, 2025 3.74 4.02 3.72 3.99 3.99 1,745,872
Oct 29, 2025 3.82 3.89 3.72 3.74 3.74 1,300,331
Oct 28, 2025 3.95 3.96 3.67 3.81 3.81 1,612,434
Oct 27, 2025 3.73 3.97 3.66 3.74 3.74 677,865
Oct 24, 2025 3.35 4.54 3.28 3.80 3.80 22,120,377
Oct 23, 2025 3.09 3.19 3.05 3.09 3.09 270,273
Oct 22, 2025 3.13 3.18 2.96 3.10 3.10 177,973
Oct 21, 2025 3.15 3.20 3.07 3.14 3.14 107,604
Oct 20, 2025 2.96 3.21 2.96 3.14 3.14 450,606
Oct 17, 2025 2.97 2.99 2.89 2.97 2.97 123,748
Oct 16, 2025 2.87 3.01 2.82 2.97 2.97 394,248
Oct 15, 2025 3.00 3.06 2.80 2.86 2.86 499,793
Oct 14, 2025 3.01 3.03 2.91 2.97 2.97 377,733
Oct 13, 2025 3.11 3.19 3.03 3.06 3.06 139,984
Oct 10, 2025 3.30 3.42 3.07 3.09 3.09 583,599
Oct 9, 2025 3.35 3.50 3.26 3.43 3.43 442,835
Oct 8, 2025 3.44 3.57 3.27 3.32 3.32 438,458
Oct 7, 2025 3.36 3.60 3.31 3.44 3.44 605,706
Oct 6, 2025 3.54 3.64 3.35 3.37 3.37 343,224
Oct 3, 2025 3.45 3.59 3.41 3.48 3.48 212,109
Oct 2, 2025 3.66 3.66 3.35 3.48 3.48 311,095
Oct 1, 2025 3.40 3.70 3.40 3.62 3.62 395,176
Sep 30, 2025 3.32 3.44 3.23 3.42 3.42 149,592
Sep 29, 2025 3.41 3.58 3.24 3.35 3.35 403,568
Sep 26, 2025 3.39 3.65 3.36 3.46 3.46 410,095
Sep 25, 2025 3.53 3.53 3.31 3.38 3.38 194,808
Sep 24, 2025 3.46 3.68 3.38 3.57 3.57 412,472
Sep 23, 2025 3.42 3.72 3.30 3.45 3.45 577,991

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
X4 Pharmaceuticals, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at XFOR, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation